Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Survey reveals problems with lung cancer mutation testing

Survey reveals problems with lung cancer mutation testing Other drugs in the class approved to treat lung cancer include Iressa (gefitinib) from AstraZeneca (AZ) and Roche/OSI's Tarceva (erlotinib), with several more coming through the pipeline.

Stratified medicines face uptake challenges in the NHS

Stratified medicines face uptake challenges in the NHS Several stratified medicines for cancer have been launched in the UK, including Pfizer's Xalkori, Roche's Tarceva and AstraZeneca's Iressa - but they have tended to face difficulties when it

Strong sales in breast cancer lift Roche revenues

Strong sales in breast cancer lift Roche revenues Tarceva. Oncology. 971. All told, Roche's pharmaceutical sales rose 4% to 9.13bn francs in the third quarter, a little ahead of analyst expectations, while its diagnostics division added 7%

Iressa blood test nears approval in Europe

Iressa blood test nears approval in Europe Roche/OSI's Tarceva(erlotinib) and Boehringer Ingelheim's recently approved Giotrif (afatinib).

Diagnostics are rising up the pharma value chain

Diagnostics are rising up the pharma value chain Relationships with pharma. This changing role can be seen with the increase in the number of companion diagnostics approved alongside important new drugs, including Roche's FDA approval for Tarceva in

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics